BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38332004)

  • 1. Application of PET imaging delta radiomics for predicting progression-free survival in rare high-grade glioma.
    Ahrari S; Zaragori T; Zinsz A; Oster J; Imbert L; Verger A
    Sci Rep; 2024 Feb; 14(1):3256. PubMed ID: 38332004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.
    Grahovac M; Spielvogel CP; Krajnc D; Ecsedi B; Traub-Weidinger T; Rasul S; Kluge K; Zhao M; Li X; Hacker M; Haug A; Papp L
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1607-1620. PubMed ID: 36738311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics model of dual-time 2-[
    Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
    Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI.
    Zhang X; Tian Q; Wang L; Liu Y; Li B; Liang Z; Gao P; Zheng K; Zhao B; Lu H
    J Magn Reson Imaging; 2018 Oct; 48(4):916-926. PubMed ID: 29394005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subregion-based positron emission tomography/computed tomography (PET/CT) radiomics model for the classification of non-small cell lung cancer histopathological subtypes.
    Shen H; Chen L; Liu K; Zhao K; Li J; Yu L; Ye H; Zhu W
    Quant Imaging Med Surg; 2021 Jul; 11(7):2918-2932. PubMed ID: 34249623
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zaragori T; Oster J; Roch V; Hossu G; Chawki MB; Grignon R; Pouget C; Gauchotte G; Rech F; Blonski M; Taillandier L; Imbert L; Verger A
    J Nucl Med; 2022 Jan; 63(1):147-157. PubMed ID: 34016731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of pre-treatment dynamic [
    Li Z; Holzgreve A; Unterrainer LM; Ruf VC; Quach S; Bartos LM; Suchorska B; Niyazi M; Wenter V; Herms J; Bartenstein P; Tonn JC; Unterrainer M; Albert NL; Kaiser L
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):535-545. PubMed ID: 36227357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted imaging and arterial spin labeling radiomics features may improve differentiation between radiation-induced brain injury and glioma recurrence.
    Zhang J; Wu Y; Wang Y; Zhang X; Lei Y; Zhu G; Mao C; Zhang L; Ma L
    Eur Radiol; 2023 May; 33(5):3332-3342. PubMed ID: 36576544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics signature from [
    Jiang C; Huang X; Li A; Teng Y; Ding C; Chen J; Xu J; Zhou Z
    Eur Radiol; 2022 Aug; 32(8):5730-5741. PubMed ID: 35298676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [
    Li Z; Kaiser L; Holzgreve A; Ruf VC; Suchorska B; Wenter V; Quach S; Herms J; Bartenstein P; Tonn JC; Unterrainer M; Albert NL
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4415-4425. PubMed ID: 34490493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of an
    Wang H; Zhao S; Li L; Tian R
    Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility on the Use of Radiomics Features of 11[C]-MET PET/CT in Central Nervous System Tumours: Preliminary Results on Potential Grading Discrimination Using a Machine Learning Model.
    Russo G; Stefano A; Alongi P; Comelli A; Catalfamo B; Mantarro C; Longo C; Altieri R; Certo F; Cosentino S; Sabini MG; Richiusa S; Barbagallo GMV; Ippolito M
    Curr Oncol; 2021 Dec; 28(6):5318-5331. PubMed ID: 34940083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing the Point Spread Function Deconvolution for Better Molecular Characterization of Newly Diagnosed Gliomas: A Dynamic
    Ahrari S; Zaragori T; Bros M; Oster J; Imbert L; Verger A
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep learning-based PET/MR radiomics for the classification of annualized relapse rate in multiple sclerosis.
    Du S; Yuan C; Zhou Q; Huang X; Meng H; Chen M; Wang H; Huang Q; Xiang S; Qian D; Li B; Chen S; Zhang M
    Mult Scler Relat Disord; 2023 Jul; 75():104750. PubMed ID: 37196386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of pulmonary lesion based on multiparametric MRI: utility of radiomics and comparison of machine learning methods.
    Wang X; Wan Q; Chen H; Li Y; Li X
    Eur Radiol; 2020 Aug; 30(8):4595-4605. PubMed ID: 32222795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of Dynamic
    Ahrari S; Zaragori T; Rozenblum L; Oster J; Imbert L; Kas A; Verger A
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.
    Dai H; Lu M; Huang B; Tang M; Pang T; Liao B; Cai H; Huang M; Zhou Y; Chen X; Ding H; Feng ST
    Quant Imaging Med Surg; 2021 May; 11(5):1836-1853. PubMed ID: 33936969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression.
    Müller M; Winz O; Gutsche R; Leijenaar RTH; Kocher M; Lerche C; Filss CP; Stoffels G; Steidl E; Hattingen E; Steinbach JP; Maurer GD; Heinzel A; Galldiks N; Mottaghy FM; Langen KJ; Lohmann P
    J Neurooncol; 2022 Sep; 159(3):519-529. PubMed ID: 35852737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.